Trader’s Watch List: AK Steel Holding Corporation (NYSE:AKS), Revance Therapeutics, Inc. (NASDAQ:RVNC), Morgans Hotel Group Co. (NASDAQ:MHGC), JinkoSolar (NYSE:JKS), Bio-Reference Laboratories (NASDAQ:BRLI)

AK Steel Holding Corporation (NYSE:AKS) belongs to Basic Materials sector. Its net profit margin is -4.60% and weekly performance is -0.19%. On last trading day company shares ended up $5.25. AK Steel Holding Corporation (NYSE:AKS) distance from 50-day simple moving average (SMA50) is 4.62%.On 29 May, AK Steel Holding Corporation (NYSE:AKS) said that its Board of Directors has approved the executive promotions and organization changes.

Revance Therapeutics, Inc. (NASDAQ:RVNC) shares increased 0.70% in last trading session and ended the day at $30.35. RVNC return on assets is -28.40%. Revance Therapeutics, Inc. (NASDAQ:RVNC) quarterly performance is 75.23%.On 4 June, Revance Therapeutics, Inc. (NASDAQ:RVNC) announced that it plans to move forward with two clinical studies for RT001, a topical gel formulation of botulinum toxin type A. The company is planning a Phase 3 study for the treatment of adults with moderate to severe crow’s feet lines and a Phase 2 study in adults with moderate to severe axillary hyperhidrosis, or excessive sweating.

On 05 June, Morgans Hotel Group Co. (NASDAQ:MHGC) shares increased 1.03% and was closed at $6.86. MHGC EPS growth in last 5 year was 6.40%. Morgans Hotel Group Co. (NASDAQ:MHGC) year to date (YTD) performance is -12.50%. On 23 May, Morgans Hotel Group Co. (NASDAQ:MHGC) said that, Jason Kalisman, the interim CEO of Morgans Hotel Group, has resigned.

On 05 June, JinkoSolar Holding Co., Ltd. (NYSE:JKS) shares moved up 5.71% and was closed at $30.72. JKS EPS growth in last 5 year was 51.60%. JinkoSolar Holding Co., Ltd. (NYSE:JKS) year to date (YTD) performance is 55.86%.On 28 May, JinkoSolar Holding Co., Ltd. (NYSE:JKS) announced its unaudited financial results for the first quarter ended March 31, 2015. Total revenues were RMB2.7 billion (US$443.5 million), representing a decrease of 7.5% from the fourth quarter of 2014 and an increase of 36.5% from the first quarter of 2014.

Bio-Reference Laboratories Inc. (NASDAQ:BRLI) shares increased 0.05% in last trading session and ended the day at $39.62. BRLI Gross Margin is 45.10% and its return on assets is 10.70%. Bio-Reference Laboratories Inc. (NASDAQ:BRLI) quarterly performance is 20.17%.Bio-Reference Laboratories Inc. (NASDAQ:BRLI) said that, Opko Health, agreed to buy clinical laboratory operator Bio-Reference Laboratories in a stock deal valued at $1.47 billion to bolster its diagnostics business.

Leave a Reply

Your email address will not be published. Required fields are marked *